Diabetes care and outcomes of pediatric refugees and migrants from Ukraine and Syria/Afghanistan with type 1 diabetes in German-speaking countries.


Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2024
Historique:
received: 19 03 2024
accepted: 23 05 2024
medline: 26 6 2024
pubmed: 26 6 2024
entrez: 26 6 2024
Statut: epublish

Résumé

Currently, over two million war refugees live in Germany. Exposure to war and flight is associated with a high burden of diseases, not limited to mental disorders and infections. We aimed to analyze diabetes treatment and outcomes of pediatric refugees and migrants from Ukraine and Syria/Afghanistan with type 1 diabetes (T1D) in German-speaking countries. We included patients with T1D documented between January 2013 and June 2023 in the German/Austrian/Luxembourgian/Swiss DPV registry, aged < 20 years, born in Ukraine [U], in Syria or Afghanistan [S/A], or without migration background [C]. Using logistic, linear, and negative binomial regression models, we compared diabetes technology use, BMI-SDS, HbA1c values, as well as severe hypoglycemia and DKA rates between groups in the first year of treatment in the host country. Results were adjusted for sex, age, diabetes duration, and time spent in the host country. Among all patients with T1D aged < 20 years, 615 were born in Ukraine [U], 624 in Syria or Afghanistan [S/A], and 28,106 had no migration background [C]. Compared to the two other groups, patients from Syria or Afghanistan had a higher adjusted BMI-SDS (0.34 [95%-CI: 0.21-0.48] [S/A] vs. 0.13 [- 0.02-0.27] [U] and 0.20 [0.19-0.21] [C]; all p<0.001), a lower use of CGM or AID system (57.6% and 4.6%, respectively [S/A] vs. 83.7% and 7.8% [U], and 87.7% and 21.8% [C], all p<0.05) and a higher rate of severe hypoglycemia (15.3/100 PY [S/A] vs. 7.6/100 PY [C], and vs. 4.8/100 PY [U], all p<0.05). Compared to the two other groups, patients from Ukraine had a lower adjusted HbA1c (6.96% [95%-CI: 6.77-7.14] [U] vs. 7.49% [7.32-7.66] [S/A] and 7.37% [7.36-7.39] [C], all p<0.001). In their first treatment year in the host country, young Syrian or Afghan refugees had higher BMI-SDS, lower use of diabetes technology, higher HbA1c, and a higher rate of severe hypoglycemia compared to young Ukrainian refugees. Diabetologists should be aware of the different cultural and socioeconomic backgrounds of refugees to adapt diabetes treatment and education to specific needs.

Identifiants

pubmed: 38919493
doi: 10.3389/fendo.2024.1403684
pmc: PMC11197464
doi:

Substances chimiques

Glycated Hemoglobin 0
Hypoglycemic Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1403684

Informations de copyright

Copyright © 2024 Auzanneau, Reinauer, Ziegler, Golembowski, de Beaufort, Schöttler, Hahn, Mirza, Galler, Wurm and Holl.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The handling editor KB declared a shared affiliation with the author AG at the time of review.

Auteurs

Marie Auzanneau (M)

Institute of Epidemiology and Medical Biometry, Ulm University, Ulm, Germany.
German Center for Diabetes Research (DZD), Neuherberg, Germany.

Christina Reinauer (C)

Department of General Pediatrics, Neonatology and Pediatric Cardiology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University, Düsseldorf, Germany.

Julian Ziegler (J)

Pediatric Diabetology, University Children's Hospital Tübingen, Tübingen, Germany.

Sven Golembowski (S)

Department of Pediatrics, Sana Hospital Lichtenberg, Berlin, Germany.

Carine de Beaufort (C)

Department of Pediatric Diabetes and Endocrinology, Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg.
Faculty of Science, Technology and Medicine, University of Luxembourg, Esch-Belval, Luxembourg.

Hannah Schöttler (H)

Diabetology and Endocrinology, Darmstädter Kinderkliniken Prinzessin Margaret, Darmstadt, Germany.

Eva Hahn (E)

Department of Pediatrics and Adolescent Medicine, St. Agnes-Hospital Bocholt - Klinikum Westmünsterland, Bocholt, Germany.

Joaquina Mirza (J)

Kinderkrankenhaus Amsterdamer Straße, Klinik für Kinder- und Jugendmedizin, Paediatric Diabetology, Kliniken Köln, Köln, Germany.

Angela Galler (A)

Charité - Universitätsmedizin Berlin, Sozialpädiatrisches Zentrum, Berlin, Germany.

Michael Wurm (M)

Department of Pediatrics, Klinik St. Hedwig, University Hospital Regensburg, Krankenhaus Barmherzige Brüder, Regensburg, Germany.

Reinhard W Holl (RW)

Institute of Epidemiology and Medical Biometry, Ulm University, Ulm, Germany.
German Center for Diabetes Research (DZD), Neuherberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH